DNAJC25-GNG10

Across TCGA pan-cancer cohorts, DNAJC25-GNG10 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of DNAJC25-GNG10’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where DNAJC25-GNG10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DNAJC25-GNG10 is over-expressed in tumor.

LUAD, STAD, and LIHC are the cancer types where DNAJC25-GNG10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DNAJC25-GNG10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	All	+0.041	.012	3	view →
STAD	All	All	+0.020	.040	2	view →
LIHC	Female	All	+0.025	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

DNAJC25-GNG10–LUAD

Open the LUAD breakdown →